Stay updated on Rilzabrutinib for CSU: H1 Resistant - Clinical Trial

Sign up to get notified when there's something new on the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Publications section updated: added a sentence clarifying that publications are automatically filled in from PubMed and may or may not be about the study, and removed the previous sentence about automatic creation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T10:29:36.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page no longer shows the government funding and operating status notice, an administrative change that does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-18T06:52:40.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    No additions or deletions were detected between the older and newer page views. The page content remains focused on the completed study details for NCT05107115 on ClinicalTrials.gov.
    Difference
    0.2%
    Check dated 2025-11-03T20:42:37.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Update includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. If no other content changes are present, this indicates a system/status update rather than content changes to core offerings.
    Difference
    2%
    Check dated 2025-10-06T04:56:05.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    - Added Revision: v3.1.0. - Removed topics: MedlinePlus related topics: Drug Safety; Counterfeit Drugs; Pharmaceutical Preparations; Substandard Drugs; Revision: v3.0.2.
    Difference
    0.4%
    Check dated 2025-09-29T02:55:27.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1, indicating a new release. The 'Back to Top' element was removed as a minor UI change; no other core content changes are detected.
    Difference
    0.1%
    Check dated 2025-09-14T18:50:00.000Z thumbnail image

Stay in the know with updates to Rilzabrutinib for CSU: H1 Resistant - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page.